15 results
PRE 14A
ALGS
Aligos Therapeutics, Inc.
16 Apr 24
Preliminary proxy
5:27pm
and Independence Rule 3526, “Communication with Audit Committees Concerning Independence”, and the Audit Committee has discussed with EY their independence … is available on our website at http://investor.aligos.com/corporate-governance/governance-overview.
Independence of the Board of Directors
S-3
EX-1.2
kva owuqimq98vk
4 Nov 21
Shelf registration
4:57pm
DEF 14A
bdmwmcyabmi69c6i1b4u
27 Apr 21
Definitive proxy
4:15pm
10-K
pv2bq
23 Mar 21
Annual report
4:26pm
8-K
EX-3.2
9fw 40lsyfcbk
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:03pm
424B4
b65b2 npsg5mnn
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1/A
tnabbiu
9 Oct 20
IPO registration (amended)
5:26pm
S-1/A
EX-3.5
v8u28s
9 Oct 20
IPO registration (amended)
5:26pm
S-1
e3tko 23jmhus
25 Sep 20
IPO registration
5:27pm
DRS
nlhjwqo23uf02ydxjkh
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next